$14.25
+0.92 (+6.90%)
Open$13.37
Previous Close$13.33
Day High$14.29
Day Low$13.34
52W High$19.70
52W Low$11.80
Volume—
Avg Volume145.4K
Market Cap172.09M
P/E Ratio—
EPS$-1.60
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
+173.3% upside
Current
$14.25
$14.25
Target
$38.94
$38.94
$25.16
$38.94 avg
$46.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 18.00M | 20.89M | 84.88M |
| Net Income | -25,349,145 | -26,472,766 | 12.73M |
| Profit Margin | -140.8% | -133.8% | 15.0% |
| EBITDA | -25,632,949 | -28,256,325 | 16.15M |
| Free Cash Flow | — | — | 13.25M |
| Rev Growth | -13.8% | -13.8% | +19.4% |
| Debt/Equity | 0.20 | 0.20 | 1.84 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |